+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Thrombus inhibition to reduce restenosis after angioplasty using monoclonal antibodies against tissue factor and the platelet GPIIb/IIIa receptor in an atherosclerotic rabbit



Thrombus inhibition to reduce restenosis after angioplasty using monoclonal antibodies against tissue factor and the platelet GPIIb/IIIa receptor in an atherosclerotic rabbit



Clinical Research 42(2): 184A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034000429

Download citation: RISBibTeXText


Related references

Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet gpiib iiia receptor correlation with bleeding time platelet aggregation and blockade of gpiib iiia receptors. Circulation 80(6): 1766-1774, 1989

Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet Gpiib/Iiia receptor. Correlation with bleeding time, platelet aggregation, and blockade of Gpiib/Iiia receptors. Circulation 80(6): 1766-1774, 1989

The effect of prolonged platelet inhibition with multiple doses of an anti-platelet glycoprotein IIb/IIIa antibody on restenosis after angioplasty in the atherosclerotic rabbit. Circulation 86(4 Suppl. 1): I226, 1992

Comparison of the antihemostatic and antithrombotic effects of monoclonal antibodies moa against von willebrand factor vwf and platelet p glycoprotein iib iiia gpiib iiia. Circulation 80(4 Suppl. 2): II24, 1989

Anti-platelet monoclonal antibodies for the prevention of arterial thrombosis: experience with ReoPro, a monoclonal antibody directed against the platelet GPIIb/IIIa receptor. Biochemical Society Transactions 23(4): 1051-1057, 1995

ACE inhibition alone and in combination with an antiplatelet Gp IIb/IIIa antibody on restenosis after angioplasty in an atherosclerotic rabbit. Clinical Research 42(2): 165A, 1994

The effect of a monoclonal antibody to the platelet glycoprotein iib iiia on restenosis after angioplasty in a rabbit model. Circulation 84(4 Suppl. 2): II332, 1991

Interaction of two GPIIb/IIIa monoclonal antibodies with platelet Fc receptor (Fc gamma RII). British Journal of Haematology 78(1): 80-86, 1991

A recombinant soluble form of the integrin GPIIb/IIIa spontaneously assumes an active, ligand-binding conformation and is recognized by GPIIb/IIIa-specific monoclonal, ALLO-, AUTO-, and drug-dependent platelet antibodies. Blood 86(10 Suppl. 1): 278A, 1995

A recombinant soluble form of the integrin alpha IIb beta 3 (GPIIb-IIIa) assumes an active, ligand-binding conformation and is recognized by GPIIb-IIIa-specific monoclonal, allo-, auto-, and drug-dependent platelet antibodies. Blood 92(6): 2053-2063, 1998

Monoclonal antibodies to platelet glycoprotein ib gpib or glycoprotein iib iiia gpiib iiia inhibit adhesion of platelets to purified solid phase von willebrand factor vwf. Federation Proceedings 46(3): 423, 1987

Blockade of the human platelet GPIIb/IIIa receptor by a murine monoclonal antibody Fab fragment (7E3): Potent dose-dependent inhibition of platelet function. Cardiovascular Drugs and Therapy 9(5): 665-675, 1995

Inhibition of Platelet GPIIb/IIIa Receptor With Monoclonal Antibody 2 Prevents Arterial, but not Venous Rethrombosis. Circulation 90(4 Part 2): I181, 1994

Tissue plasminogen activator tpa resistant platelet rich white thrombus wt and combination treatment of tpa and antiplatelet antibody to gpiib iiia receptor 7e3. Circulation 78(4 Part 2): II15, 1988

Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies. Blood 67(5): 1356-1366, 1986